Full Description
There is a growing body of data supporting the usage of cannabis and cannabis-related products in alleviating or preventing symptoms in different diseases and conditions. Medicinal Usage of Cannabis and Cannabinoids offers readers a comprehensive reference on the medical usage and symptom relief provided by these compounds in a variety of disorders. With coverage of neurological diseases like Alzheimer's and Parkinson's, and a wide range of other afflictions including depression, anxiety, nausea, and cancer, this broad coverage allows readers to learn about symptom control but also physiological, psychological, and pharmacological effects of these compounds. Unique case reports are provided as well. This volume provides a platform for research on the use of these compounds in improving patient care, brain function, and neurological dysfunction.
Contents
Preface
I. Setting the scene and introductory chapters
1. How medical cannabis may influence the future of medicine
Martha Rosenthal
2. Medical cannabis and cannabinoids: how best to extract components from plant material
Roberta Costi
3. Medicinal usage of cannabis and its impact on mental health among cancer patients and survivors
Nicolas Hernandez Ortega, Ye Chen, Jessica Y. Islam, Diane Rodriguez, Marlene Camacho-Rivera and Denise Christina Vidot
4. Cannabis sativa as a traditional phytomedicine: a new narrative covering different countries
Md Nasir Ahmed, Tridib Paul, Md. Nur Kabidul Azam, Rownak Jahan and Mohammed Rahmatullah
5. Medical use of cannabis in the middle east
Bader Hamza Shirah, Mohammed Ahmed and Ruba Saleh
6. What medicinal cannabis is used for: a focus on Canada
Dean T. Eurich, Cerina Lee and Jason Dyck
7. New York perspectives of medical cannabis laboratory analysis
Lingyun Li, Stacey Chmura, Christopher Judd and Bryan C. Duffy
8. Potential roles of epigenetic memory on the quality of clonal cannabis plants: Content and profile of secondary metabolites
Mohsen Hesami and Max Jones
9. Aberrant use of medicinal cannabis: theoretical and empirical considerations
Daniel Feingold
10. Profile of older users of medical cannabis and cannabinoids
Joshua Brown
11. Use of cannabidiol oil by caregivers: a focus on Alzheimer's disease
Magdalena Leszko
12. Medicinal use of cannabis: adverse events as a balanced perspective
Giada Crescioli, Valentina Maggini, Fabio Firenzuoli, Alfredo Vannacci and Niccolo Lombardi
II. Physiological aspects and metabolic aspects
13. Physiopathology and use of cannabinoids for fibrotic diseases
Carmen del Rio and E. Munoz
14. Cannabinoids in inflammation and atherosclerosis
Leonor Thomson, Edward Moreira-Bahnson and Bruno Musetti
15. Targeting the CB(2) receptors and other endocannabinoid elements to delay disease progression in cardiovascular diseases
Shreesh Ojha
16. BMI in cannabis users: regulation, mechanisms and public health impact
Thomas Clark
III. Neurological, psychological and behavioural aspects
17. Neuroprotection by cannabis related products, cannabidiol and cannabigerol, and associated mechanisms of action
Carolina Echeverry Sr., Jimena Fagetti, Miguel Reyes-Parada and Cecilia Scorza
18. Cannabis terpenes as neuroprotective agents: a focus on alpha-bisabolol
John Staton Laws, Srijan Shrestha and Scott D. Smid
19. Cannabidiol in medicinal usage of stress: modelling investigations into cocaine
M. Julia García-Fuster and Olga Valverde
20. Medicinal cannabis and neurocognition impairment
Caroline MacCallum, April Christiansen, Lindsay Lo, Carly Pistawka, Michael Boivin and Melissa Snider-Adler
21. Genetic models of audiogenic seizures: what they are and how cannabinoids and Cannabis-derived compounds can be used to alleviate their symptoms - an updated narrative
Norberto Garcia-Cairasco
22. Addressing the validity of cannabinoid therapy as an option for the treatment of substance use disorder
Rose Chesworth, Erin McLemon and Tim Karl
IV. Pharmacological and cellular aspects
23. Cannabidiolic acid (CBDA), features and profiles: anti-hyperalgesic effects
G. Singh, Katja Linher-Melville and Raphael Mechoulam
24. Cannabis-drug interactions: implications for medicinal cannabis use
Fran Gengo, Anna Mattle and Christopher Ralyea
25. Cannabinoid receptor subtype 2 (CB2R): features and targets for medical applications
Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, Francesco Leonetti and Angela Stefanachi
26. Medical use of cannabidiol and impact on cancer cell viability
Kent E. Chair and Wesley Raup-Konsavage
27. Anti-inflammatory and antioxidant and immunomodulatory effects of phytocannabinoid β‑caryophyllene: A mechanistic overview
Vafa Baradaran Rahimi, Arghavan Memarzia and Prof. Vahid Reza Askari
V. Symptom Control and Medicinal Uses
28. Cancer patients and providers: Attitudes and beliefs of cannabis and cannabinoids use as a treatment
Kimberson Tanco
29. CBD (cannabidiol) use in breast cancer chemotherapy
Ana I. Torres-Suarez, Ana Isabel Fraguas-Sánchez and Ana Fernández-Carballido
30. Sleep: cannabis and cannabinoids use
Eric Murillo-Rodríguez
31. Cannabis and cannabis related products and their uses in aiding sexual health of men and women
Lynnette Nathalie Lyzwinski
32. Symptom control in palliative care settings: The role of cannabis-based medicines
Maximillian Stevenson and Leah Sera
33. Cannabidiol (CBD) Use in Fragile X Spectrum Disorders
Devon Johnson and Randi J. Hagerman
34. Hempseed (Cannabis sativa) and ameliorative effects in hypercholesterolemia
NAVEEN KAUSHAL
35. Benzodiazepines and cannabis use
Chad Alexander Purcell
36. Features of (+)-trans-cannabidiol-2-hydroxy pentyland applications to disease: a focus on usage in diabetic nephropathy
E. Munoz, Matthias Winkler, Marcus Goetz and Isabel Gonzalez Mariscal
37. Medical use of cannabis: applications to Tourette syndrome
Kirsten R. Müller-Vahl and Natalia Szejko
38. Cannabinoids and their use in chronic non-cancer pain: a new narrative review
Stanley Sau-Ching Wong and Chi Wai Cheung
39. Endometriosis: features and potential role of medical cannabis
Mike Armour and Justin Sinclair
40. Cannabis usage for Crohn's disease and ulcerative colitis: a narrative
Joseph Feuerstein and Rajsavi Anand
41. Medical cannabis and use in migraine
Jessica Jiang and Alasdair M. Barr
42. Cannabidiol (CBD ) and potential in medicinal use in rheumatoid arthritis
Torsten Lowin
43. Role of Cannabinoids in Glaucoma: Lowering Intraocular Pressure or Neuroprotection
Ujendra Kumar, Sneha Singh and Rishi Somvanshi
44. Medicinal potential of anandamide as a representative endocannabinoid and its effect at the cellular level in skin
Adrianna Maria Piasek and Anna Sobiepanek
VI. Resources
45. Medical Cannabis and Resources
Rajkumar Rajendram
